Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2005 Nov;97(11):1547–1549.

Euthyroid Graves' ophthalmopathy with negative autoantibodies.

Mehtap Cakir 1
PMCID: PMC2594903  PMID: 16334503

Abstract

Graves' disease is an autoimmune-based hyperthyroidism in which a number of different antibodies directed against thyroid tissue plays a role. Graves' ophthalmopathy is thought to be a consequence of this autoimmune basis and occurs in some patients with Graves' disease. On occasional cases, the disease may present only with ophthalmopathy without hyperthyroidism. A 32-year-old woman with euthyroid Graves' ophthalmopathy and negative thyroid autoantibodies, including TSH receptor antibody, is presented here.

Full text

PDF
1548

Images in this article

1548Figure 1
on p.1548
1548Figure 2
on p.1548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Costagliola S., Morgenthaler N. G., Hoermann R., Badenhoop K., Struck J., Freitag D., Poertl S., Weglöhner W., Hollidt J. M., Quadbeck B. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab. 1999 Jan;84(1):90–97. doi: 10.1210/jcem.84.1.5415. [DOI] [PubMed] [Google Scholar]
  2. Ealey P. A., Marshall N. J., Lawton N., Dandona P., Lightman S., Ekins R. P. The application of a cytochemical bioassay to measure thyroid stimulating antibodies; a study of patients with euthyroid Graves' ophthalmopathy. J Endocrinol Invest. 1984 Dec;7(6):597–602. doi: 10.1007/BF03349492. [DOI] [PubMed] [Google Scholar]
  3. Gerding M. N., van der Meer J. W., Broenink M., Bakker O., Wiersinga W. M., Prummel M. F. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2000 Mar;52(3):267–271. doi: 10.1046/j.1365-2265.2000.00959.x. [DOI] [PubMed] [Google Scholar]
  4. Goh S. Y., Ho S. C., Seah L. L., Fong K. S., Khoo D. H. C. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol (Oxf) 2004 May;60(5):600–607. doi: 10.1111/j.1365-2265.2004.02033.x. [DOI] [PubMed] [Google Scholar]
  5. Khoo D. H., Eng P. H., Ho S. C., Tai E. S., Morgenthaler N. G., Seah L. L., Fong K. S., Chee S. P., Choo C. T., Aw S. E. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000 Dec;10(12):1093–1100. doi: 10.1089/thy.2000.10.1093. [DOI] [PubMed] [Google Scholar]
  6. Khoo D. H., Ho S. C., Seah L. L., Fong K. S., Tai E. S., Chee S. P., Eng P. H., Aw S. E., Fok A. C. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid. 1999 Dec;9(12):1175–1180. doi: 10.1089/thy.1999.9.1175. [DOI] [PubMed] [Google Scholar]
  7. Kim W. B., Chung H. K., Park Y. J., Park D. J., Lee H. K., Cho B. Y. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies. Korean J Intern Med. 2001 Sep;16(3):187–200. doi: 10.3904/kjim.2001.16.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kim W. B., Chung H. K., Park Y. J., Park D. J., Tahara K., Kohn L. D., Cho B. Y. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid. 2000 Jul;10(7):579–586. doi: 10.1089/thy.2000.10.579. [DOI] [PubMed] [Google Scholar]
  9. Maciel L. M., Rodrigues S. S., Dibbern R. S., Navarro P. A., Donadi E. A. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid. 2001 Jan;11(1):31–35. doi: 10.1089/10507250150500630. [DOI] [PubMed] [Google Scholar]
  10. Noh J. Y., Hamada N., Inoue Y., Abe Y., Ito K., Ito K. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid. 2000 Sep;10(9):809–813. doi: 10.1089/thy.2000.10.809. [DOI] [PubMed] [Google Scholar]
  11. Orhan Y., Azezli A., Carin M., Aral F., Sencer E., Molvalilar S. Human lymphocyte antigens (HLA) and Graves' disease in Turkey. J Clin Immunol. 1993 Sep;13(5):339–343. doi: 10.1007/BF00920242. [DOI] [PubMed] [Google Scholar]
  13. Prabhakar Bellur S., Bahn Rebecca S., Smith Terry J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003 Dec;24(6):802–835. doi: 10.1210/er.2002-0020. [DOI] [PubMed] [Google Scholar]
  14. Tellez M., Cooper J., Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol (Oxf) 1992 Mar;36(3):291–294. doi: 10.1111/j.1365-2265.1992.tb01445.x. [DOI] [PubMed] [Google Scholar]
  15. Watanabe M., Iwatani Y., Kashiwai T., Iijima T., Fujikado T., Amino N. Euthyroid Graves' disease showing no thyroid abnormalities except positive thyroid-stimulating antibody (TSAb): two case reports. J Intern Med. 1995 Oct;238(4):379–384. doi: 10.1111/j.1365-2796.1995.tb01214.x. [DOI] [PubMed] [Google Scholar]
  16. de Juan E., Jr, Hurley D. P., Sapira J. D. Racial differences in normal values of proptosis. Arch Intern Med. 1980 Sep;140(9):1230–1231. doi: 10.1001/archinte.140.9.1230. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES